Ranbaxy Laboratories Ltd has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter and nine months year ended September 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on October 26, 2009) that: "With the references to qualification of the previous statutory auditors as mentioned in their report on the accounts of the Company for the year ended December 31, 2008, Central Government vide letter dated May 12, 2009, approved the waiver of recovery of excess remuneration paid to the working Directors of the Company. The Company has made an application to the Central Government for waiver of recovery of excess remuneration paid to Mr. Malvinder Mohan Singh for the period from December 19, 2008 to December 31, 2008".